European Monitoring Centre for Drugs and Drug Addiction
Datos de la institución
| Tipo | GOVERNMENT (active) |
|---|---|
| País | Lisbon, PT |
| Trabajos | 66 |
| Investigadores | 68 |
| Citas | 30 |
| Índice h | 3 |
| Índice i10 | 1 |
| Cobertura | 1998 - 2026 |
| ROR | 028mr0844 |
| GRID | grid.418926.0 |
| Wikidata | Q1377256 |
| OpenAlex | I2799855956 |
| Sitio web | http://www.emcdda.europa.eu |
| También conocida como | European Monitoring Centre for Drugs and Drug Addiction; Observatório Europeu da Droga e da Toxicodependência |
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated
Unlocking spatiotemporal insights in crack cocaine use in Europe through a wastewater-based epidemiology approach
Relationships Between Motives for Cannabis and Cannabidiol Use in People Who Co‐Use
What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate
World addiction medicine reports
The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates
Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)
Do Sex Differences and Risk Perception Affect Cannabis Exposure? Results from a Sample of Current Cannabis Users from the European Web Survey on Drugs
Opioid Agonist Maintenance Treatment Outcomes—The Optimus International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report
Identifying the impact of the business cycle on drug-related harms in European countries
Prevalence of illicit drug use before imprisonment in Europe
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
Synthetic Cannabinoids and Cannabis
Impact of Covid-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Implementation of the Icelandic Prevention Model
Monitoring drug trends in the digital environment–New methods, challenges and the opportunities provided by automated approaches
Supporting Future Cannabis Policy – Developing a Standard Joint Unit
Tell Me How Much Your Friends Consume”—Personal, Behavioral, Social, and Attitudinal Factors Associated with Alcohol and Cannabis Use among European School Students
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018
Standard units for cannabis dose
Prevention and Control of Covid-19 in Italian Prisons
Hepatitis C virus infection in EU/EEA and United Kingdom prisons
Expenditure on the treatment of drug and alcohol disorders in hospitals
Sources of drug acquisition among females and males in the European Web Survey on Drugs
Poverty, vulnerability, and provision of healthcare in Afghanistan
The Institutionalization of Eu Agencies
Drugs Importation and the Bifurcation of Risk
Is universal prevention against youths’ substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial
More free syringes, fewer drug injectors in the case of Spain
Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)
Is the Strengthening Families Programme feasible in Europe
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated
Unlocking spatiotemporal insights in crack cocaine use in Europe through a wastewater-based epidemiology approach
Relationships Between Motives for Cannabis and Cannabidiol Use in People Who Co‐Use
What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate
World addiction medicine reports
The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates
Do Sex Differences and Risk Perception Affect Cannabis Exposure? Results from a Sample of Current Cannabis Users from the European Web Survey on Drugs
Opioid Agonist Maintenance Treatment Outcomes—The Optimus International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report
Identifying the impact of the business cycle on drug-related harms in European countries
Prevalence of illicit drug use before imprisonment in Europe
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
Synthetic Cannabinoids and Cannabis
Impact of Covid-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Implementation of the Icelandic Prevention Model
Monitoring drug trends in the digital environment–New methods, challenges and the opportunities provided by automated approaches
Supporting Future Cannabis Policy – Developing a Standard Joint Unit
Tell Me How Much Your Friends Consume”—Personal, Behavioral, Social, and Attitudinal Factors Associated with Alcohol and Cannabis Use among European School Students
Drugs Importation and the Bifurcation of Risk
A small area analysis estimating the prevalence of addiction to opioids in Barcelona, 1993
Lack of reductions in drug use may point to harm reduction
An overview of opiate substitution treatment in the European Union and Norway
Estimating Local and National Problem Drug Use Prevalence from Demographics
Can HIV epidemics among IDUs ‘trigger’ a generalised epidemic
Patients in long-term maintenance therapy for drug use in Italy
More free syringes, fewer drug injectors in the case of Spain
Quantitative and qualitative estimates of cross-border tobacco shopping and tobacco smuggling in France
Injecting Equipment Sharing in Russian Drug Injecting Dyads
The cocaine and heroin markets in the era of globalisation and drug reduction policies
Globalization and the price decline of illicit drugs
Is universal prevention against youths’ substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial
Drug harms in the UK
Unprotected Sex in Heterosexual Partnerships of Injecting Drug Users in St. Petersburg, Russia
Khat use and monitoring drug use in Europe
The Institutionalization of Eu Agencies
Quantitative Surveys in Hard-to-Reach Populations
Poverty, vulnerability, and provision of healthcare in Afghanistan
Cost of disorders of the brain in Europe 2010
Economic recession, drug use and public health
Unemployment and drug treatment
The association between social marginalisation and the injecting of alcohol amongst IDUs in Budapest, Hungary
Ten Years of Monitoring Illicit Drug Use in Prison Populations in Europe
Mortality among people who inject drugs
| ARTICLE | 66 |
|---|
| 2026 | 3 |
|---|---|
| 2025 | 1 |
| 2024 | 4 |
| 2023 | 3 |
| 2022 | 4 |
| 2021 | 6 |
| 2020 | 4 |
| 2019 | 2 |
| 2018 | 6 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 3 |
| 2014 | 2 |
| 2013 | 1 |
| 2011 | 5 |